T 0277/95 (Production of erythropoietin/GENETICS INSTITUTE) of 16.04.1999
- European Case Law Identifier
- ECLI:EP:BA:1999:T027795.19990416
- Date of decision
- 16 April 1999
- Case number
- T 0277/95
- Petition for review of
- -
- Application number
- 90118215.4
- IPC class
- C12N 15/16
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen and members (B)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Method for the production of erythropoietin
- Applicant name
- GENETICS INSTITUTE, INC.
- Opponent name
- JANSSEN-CILAG GmbH
AMGEN INC.
HOECHST AG - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2) 1973European Patent Convention Art 123(2) 1973European Patent Convention Art 123(3) 1973European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973European Patent Convention Art 84 1973European Patent Convention Art 87 1973European Patent Convention Art 88 1973
- Keywords
- Main request - broadening of scope of claims (no)
Added subject-matter (no)
Clarity (yes)
Right to priority (denied)
Novelty (yes)
Inventive step (yes)
Sufficiency of disclosure (yes) - Catchword
- "Inherency" has to be established on the basis of certainty, not probability or possibility (cf point 15 of the reasons).
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent on the basis of the appellant's main request, and the description and figures as requested by the appellant in the oral proceedings.